MAPKK2 (1-16) (human, mouse, rat) is an N-terminal peptide fragment from MEK2 used to study regulatory phosphorylation and protein–protein docking. Its conserved sequence includes motifs critical for kinase activation. Researchers employ it in assays exploring scaffolding and upstream signaling complexes. The peptide aids comparative MAPK-pathway investigations across species.
CAT No: P6620
Synonyms/Alias:Dual Specifity Mitogen-Activated Protein Kinase Kinase 2 (1-16) (human, mouse, rat), ERK Activator Kinase 2 (1-16) (human, mouse, rat), MAP Kinase Kinase 2 (1-16) (human, mouse, rat), MAPK/ERK Kinase 2 (1-16) (human, mouse, rat), MEK2 (1-16) (human, mouse
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More